Using data-independent, high-resolution mass spectrometry in protein biomarker research: Perspectives and clinical applications

Proteomics - Clinical Applications

Volumn 9, Issue 3-4, 2015, Pages 307-321

  Sajic, Tatjana ^a   Liu, Yansheng ^a   Aebersold, Ruedi ^a,b  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Biomarker; Data independent acquisition (DIA); Mass spectrometry; Proteomics; SWATH mass spectrometry

Indexed keywords

BIOLOGICAL MARKER; PROTEIN;

ACCURACY; BIOASSAY; BLOOD SAMPLING; DATA PROCESSING; ENANTIOSELECTIVITY; HIGH THROUGHPUT SCREENING; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR LIBRARY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEOMICS; REPRODUCIBILITY; REVIEW; TISSUES; VALIDATION STUDY; ANIMAL; PROCEDURES;

ANIMALS; BIOMARKERS; HUMANS; MASS SPECTROMETRY;

EID: 84928048755     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201400117     Document Type: Review

References (112)

1. Kitano, H., Computational systems biology. Nature 2002, 420, 206-210.
2. Kitano, H., Systems biology: a brief overview. Science 2002, 295, 1662-1664.
3. Lamond, A. I., Uhlen, M., Horning, S., Makarov, A. et al., Advancing cell biology through proteomics in space and time (PROSPECTS). Mol. Cell. Proteomics 2012, 11, O112 017731.
4. Polanski, M., Anderson, N. L., A list of candidate cancer biomarkers for targeted proteomics. Biomark. Insights 2007, 1, 1-48.
5. Haug, U., Rothenbacher, D., Wente, M. N., Seiler, C. M. et al., Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patients. Br. J. Cancer 2007, 96, 1329-1334.
6. Shackleton, M., Quintana, E., Fearon, E. R., Morrison, S. J., Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 2009, 138, 822-829.
7. Parker, C. E., Borchers, C. H., Mass spectrometry based biomarker discovery, verification, and validation-quality assurance and control of protein biomarker assays. Mol. Oncol. 2014, 8, 840-858.
8. Kulasingam, V., Pavlou, M. P., Diamandis, E. P., Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer. Nat. Rev. Cancer 2010, 10, 371-378.
9. Nilsson, T., Mann, M., Aebersold, R., Yates, J. R., 3rd et al., Mass spectrometry in high-throughput proteomics: ready for the big time. Nat. Methods 2010, 7, 681-685.
10. Weston, A. D., Hood, L., Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J. Proteome Res. 2004, 3, 179-196.
11. Hamburg, M. A., Collins, F. S., The path to personalized medicine. N. Engl. J. Med. 2010, 363, 301-304.
12. Ahrens, C. H., Brunner, E., Qeli, E., Basler, K., Aebersold, R., Generating and navigating proteome maps using mass spectrometry. Nat. Rev. Mol. Cell Biol. 2010, 11, 789-801.
13. Liu, Y., Huttenhain, R., Collins, B., Aebersold, R., Mass spectrometric protein maps for biomarker discovery and clinical research. Expert Rev. Mol. Diagn. 2013, 13, 811-825.
14. Rask-Andersen, M., Almen, M. S., Schioth, H. B., Trends in the exploitation of novel drug targets. Nat. Rev. Drug Discov. 2011, 10, 579-590.
15. Parker, C. E., Pearson, T. W., Anderson, N. L., Borchers, C. H., Mass-spectrometry-based clinical proteomics-a review and prospective. Analyst 2010, 135, 1830-1838.
16. Sawyers, C. L., The cancer biomarker problem. Nature 2008, 452, 548-552.
17. Huttenhain, R., Soste, M., Selevsek, N., Rost, H. et al., Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics. Sci. Transl. Med. 2012, 4, 142ra194.
18. Anderson, N. L., The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clin. Chem. 2010, 56, 177-185.
19. Zhang, B., Wang, J., Wang, X., Zhu, J. et al., Proteogenomic characterization of human colon and rectal cancer. Nature 2014, 513, 382-387.
20. Poste, G., Bring on the biomarkers. Nature 2011, 469, 156-157.
21. Kim, K., Kim, Y., Preparing multiple-reaction monitoring for quantitative clinical proteomics. Expert Rev. Proteomics 2009, 6, 225-229.
22. Palmblad, M., Tiss, A., Cramer, R., Mass spectrometry in clinical proteomics-from the present to the future. Proteomics Clin. Appl. 2009, 3, 6-17.
23. Paulovich, A. G., Whiteaker, J. R., Hoofnagle, A. N., Wang, P., The interface between biomarker discovery and clinical validation: the tar pit of the protein biomarker pipeline. Proteomics Clin. Appl. 2008, 2, 1386-1402.
24. Law, K. P., Lim, Y. P., Recent advances in mass spectrometry: data independent analysis and hyper reaction monitoring. Expert Rev. Proteomics 2013, 10, 551-566.
25. Kellie, J. F., Tran, J. C., Lee, J. E., Ahlf, D. R. et al., The emerging process of top down mass spectrometry for protein analysis: biomarkers, protein-therapeutics, and achieving high throughput. Mol. Biosyst. 2010, 6, 1532-1539.
26. Aebersold, R., Mann, M., Mass spectrometry-based proteomics. Nature 2003, 422, 198-207.
27. Domon, B., Aebersold, R., Options and considerations when selecting a quantitative proteomics strategy. Nat. Biotechnol. 2010, 28, 710-721.
28. McDonald, W. H., Yates, J. R., 3rd, Shotgun proteomics and biomarker discovery. Dis. Markers 2002, 18, 99-105.
29. Delahunty, C. M., Yates, J. R., 3rd, MudPIT: multidimensional protein identification technology. Biotechniques 2007, 43, 563, 565, 567 passim.
30. Kim, M. S., Pinto, S. M., Getnet, D., Nirujogi, R. S. et al., A draft map of the human proteome. Nature 2014, 509, 575-581.
31. Wilhelm, M., Schlegl, J., Hahne, H., Moghaddas Gholami, A. et al., Mass-spectrometry-based draft of the human proteome. Nature 2014, 509, 582-587.
32. Andrews, G. L., Dean, R. A., Hawkridge, A. M., Muddiman, D. C., Improving proteome coverage on a LTQ-Orbitrap using design of experiments. J. Am. Soc. Mass Spectrom. 2011, 22, 773-783.
33. Andrews, G. L., Simons, B. L., Young, J. B., Hawkridge, A. M., Muddiman, D. C., Performance characteristics of a new hybrid quadrupole time-of-flight tandem mass spectrometer (TripleTOF 5600). Anal. Chem. 2011, 83, 5442-5446.
34. Liu, H., Sadygov, R. G., Yates, J. R., 3rd, A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 2004, 76, 4193-4201.
35. Michalski, A., Cox, J., Mann, M., More than 100, 000 detectable peptide species elute in single shotgun proteomics runs but the majority is inaccessible to data-dependent LC-MS/MS. J. Proteome Res. 2011, 10, 1785-1793.
36. Picotti, P., Aebersold, R., Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat. Methods 2012, 9, 555-566.
37. Reiter, L., Rinner, O., Picotti, P., Huttenhain, R. et al., mProphet: automated data processing and statistical validation for large-scale SRM experiments. Nat. Methods 2011, 8, 430-435.
38. Cima, I., Schiess, R., Wild, P., Kaelin, M. et al., Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proc. Natl. Acad. Sci. USA 2011, 108, 3342-3347.
39. Surinova, S., Huttenhain, R., Chang, C. Y., Espona, L. et al., Automated selected reaction monitoring data analysis workflow for large-scale targeted proteomic studies. Nat. Protoc. 2013, 8, 1602-1619.
40. Lange, V., Picotti, P., Domon, B., Aebersold, R., Selected reaction monitoring for quantitative proteomics: a tutorial. Mol. Syst. Biol. 2008, 4, 222.
41. Addona, T. A., Abbatiello, S. E., Schilling, B., Skates, S. J. et al., Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat. Biotechnol. 2009, 27, 633-641.
42. Surinova, S., Schiess, R., Huttenhain, R., Cerciello, F. et al., On the development of plasma protein biomarkers. J. Proteome Res. 2011, 10, 5-16.
43. Peterson, A. C., Russell, J. D., Bailey, D. J., Westphall, M. S., Coon, J. J., Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol. Cell. Proteomics 2012, 11, 1475-1488.
44. Elias, J. E., Haas, W., Faherty, B. K., Gygi, S. P., Comparative evaluation of mass spectrometry platforms used in large-scale proteomics investigations. Nat. Methods 2005, 2, 667-675.
45. Chapman, J. D., Goodlett, D. R., Masselon, C. D., Multiplexed and data-independent tandem mass spectrometry for global proteome profiling. Mass Spectrom. Rev. 2014, 33, 452-470.
46. Soste, M., Hrabakova, R., Wanka, S., Melnik, A. et al., A sentinel protein assay for simultaneously quantifying cellular processes. Nat. Methods 2014, 11, 1045-1048.
47. Egertson, J. D., Kuehn, A., Merrihew, G. E., Bateman, N. W. et al., Multiplexed MS/MS for improved data-independent acquisition. Nat. Methods 2013, 10, 744-746.
48. Gillet, L. C., Navarro, P., Tate, S., Rost, H. et al., Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol. Cell. Proteomics 2012, 11, O111 016717.
49. Purvine, S., Eppel, J. T., Yi, E. C., Goodlett, D. R., Shotgun collision-induced dissociation of peptides using a time of flight mass analyzer. Proteomics 2003, 3, 847-850.
50. Venable, J. D., Dong, M. Q., Wohlschlegel, J., Dillin, A., Yates, J. R., Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra. Nat. Methods 2004, 1, 39-45.
51. Panchaud, A., Jung, S., Shaffer, S. A., Aitchison, J. D., Goodlett, D. R., Faster, quantitative, and accurate precursor acquisition independent from ion count. Anal. Chem. 2011, 83, 2250-2257.
52. Panchaud, A., Scherl, A., Shaffer, S. A., von Haller, P. D. et al., Precursor acquisition independent from ion count: how to dive deeper into the proteomics ocean. Anal. Chem. 2009, 81, 6481-6488.
53. Plumb, R. S., Johnson, K. A., Rainville, P., Smith, B. W. et al., UPLC/MS(E); a new approach for generating molecular fragment information for biomarker structure elucidation. Rapid Commun. Mass Spectrom. 2006, 20, 1989-1994.
54. Carvalho, P. C., Han, X., Xu, T., Cociorva, D. et al., XDIA: improving on the label-free data-independent analysis. Bioinformatics 2010, 26, 847-848.
55. Silva, J. C., Denny, R., Dorschel, C. A., Gorenstein, M. et al., Quantitative proteomic analysis by accurate mass retention time pairs. Anal. Chem. 2005, 77, 2187-2200.
56. Levin, Y., Hradetzky, E., Bahn, S., Quantification of proteins using data-independent analysis (MSE) in simple and complex samples: a systematic evaluation. Proteomics 2011, 11, 3273-3287.
57. Distler, U., Kuharev, J., Navarro, P., Levin, Y. et al., Drift time-specific collision energies enable deep-coverage data-independent acquisition proteomics. Nat. Methods 2014, 11, 167-170.
58. Wang, L., Lockstone, H. E., Guest, P. C., Levin, Y. et al., Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia. J. Proteome Res. 2010, 9, 521-527.
59. Krishnamurthy, D., Levin, Y., Harris, L. W., Umrania, Y. et al., Analysis of the human pituitary proteome by data independent label-free liquid chromatography tandem mass spectrometry. Proteomics 2011, 11, 495-500.
60. Levin, Y., Wang, L., Schwarz, E., Koethe, D. et al., Global proteomic profiling reveals altered proteomic signature in schizophrenia serum. Mol. Psychiatry 2010, 15, 1088-1100.
61. Hughes, M. A., Silva, J. C., Geromanos, S. J., Townsend, C. A., Quantitative proteomic analysis of drug-induced changes in mycobacteria. J. Proteome Res. 2006, 5, 54-63.
62. Silva, J. C., Denny, R., Dorschel, C., Gorenstein, M. V. et al., Simultaneous qualitative and quantitative analysis of the Escherichia coli proteome: a sweet tale. Mol. Cell. Proteomics 2006, 5, 589-607.
63. Cortezzi, S. S., Garcia, J. S., Ferreira, C. R., Braga, D. P. et al., Secretome of the preimplantation human embryo by bottom-up label-free proteomics. Anal. Bioanal. Chem. 2011, 401, 1331-1339.
64. Geiger, T., Cox, J., Mann, M., Proteomics on an Orbitrap benchtop mass spectrometer using all-ion fragmentation. Mol. Cell. Proteomics 2010, 9, 2252-2261.
65. Michalski, A., Damoc, E., Hauschild, J. P., Lange, O. et al., Mass spectrometry-based proteomics using Q Exactive, a high-performance benchtop quadrupole Orbitrap mass spectrometer. Mol. Cell. Proteomics 2011, 10, M111 011015.
66. Jung, S., Smith, J. J., von Haller, P. D., Dilworth, D. J. et al., Global analysis of condition-specific subcellular protein distribution and abundance. Mol. Cell. Proteomics 2013, 12, 1421-1435.
67. Acosta-Martin, A. E., Panchaud, A., Chwastyniak, M., Dupont, A. et al., Quantitative mass spectrometry analysis using PAcIFIC for the identification of plasma diagnostic biomarkers for abdominal aortic aneurysm. PLoS One 2011, 6, e28698.
68. Voss, J., Goo, Y. A., Cain, K., Woods, N. et al., Searching for the noninvasive biomarker holy grail: are urine proteomics the answer? Biol. Res. Nursing 2011, 13, 235-242.
69. Goo, Y. A., Cain, K., Jarrett, M., Smith, L. et al., Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups. J. Proteome Res. 2012, 11, 5650-5662.
70. Hengel, S. M., Murray, E., Langdon, S., Hayward, L. et al., Data-independent proteomic screen identifies novel tamoxifen agonist that mediates drug resistance. J. Proteome Res. 2011, 10, 4567-4578.
71. Weisbrod, C. R., Eng, J. K., Hoopmann, M. R., Baker, T., Bruce, J. E., Accurate peptide fragment mass analysis: multiplexed peptide identification and quantification. J. Proteome Res. 2012, 11, 1621-1632.
72. MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M. et al., Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 2010, 26, 966-968.
73. Vogelsang, M. S., Prakash, A., Sarracino, D., Vadali, G. et al., Characterizing qualitative and quantitative global changes in the aging heart using pSMART, a novel acquisition method (http://www.thermoscientific.com/).
74. Prakash, A., Peterman, S., Ahmad, S., Sarracino, D. et al., Hybrid data acquisition and processing strategies with increased throughput and selectivity: pSMART analysis for global qualitative and quantitative analysis. J. Proteome Res. 2014, 13, 5415-5430.
75. Kiyonami, R., Vogelsang, M. S., Zabrouskov, V., Huhmer, A. et al., Large scale targeted protein quantification using WiSIM-DIA workflow on a Orbitrap fusion tribrid mass spectrometer. Thermo Scientific Application Note 600 2014. http://www.thermoscientific.com/en/product/orbitrap-fusion-tribrid-mass-spectrometer.html.
76. Liu, Y., Huttenhain, R., Surinova, S., Gillet, L. C. et al., Quantitative measurements of N-linked glycoproteins in human plasma by SWATH-MS. Proteomics 2013, 13, 1247-1256.
77. Liu, Y., Chen, J., Sethi, A., Li, Q. K. et al., Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness. Mol. Cell. Proteomics 2014, 13, 1753-1768.
78. Zhang, F., Lin, H., Gu, A., Li, J. et al., SWATH- and iTRAQ-based quantitative proteomic analyses reveal an overexpression and biological relevance of CD109 in advanced NSCLC. J. Proteomics 2014, 102, 125-136.
79. Findlay, G. M., Smith, M. J., Lanner, F., Hsiung, M. S. et al., Interaction domains of Sos1/Grb2 are finely tuned for cooperative control of embryonic stem cell fate. Cell 2013, 152, 1008-1020.
80. Escher, C., Reiter, L., MacLean, B., Ossola, R. et al., Using iRT, a normalized retention time for more targeted measurement of peptides. Proteomics 2012, 12, 1111-1121.
81. Lee, H. J., Lee, E. Y., Kwon, M. S., Paik, Y. K., Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics. Curr. Opin. Chem. Biol. 2006, 10, 42-49.
82. Zhang, H., Li, X. J., Martin, D. B., Aebersold, R., Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 2003, 21, 660-666.
83. Kalin, M., Cima, I., Schiess, R., Fankhauser, N. et al., Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome. Eur. Urol. 2011, 60, 1235-1243.
84. Zhang, H., Liu, A. Y., Loriaux, P., Wollscheid, B. et al., Mass spectrometric detection of tissue proteins in plasma. Mol. Cell. Proteomics 2007, 6, 64-71.
85. Schiess, R., Wollscheid, B., Aebersold, R., Targeted proteomic strategy for clinical biomarker discovery. Mol. Oncol. 2009, 3, 33-44.
86. Zhang, H., Yi, E. C., Li, X. J., Mallick, P. et al., High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry. Mol. Cell. Proteomics 2005, 4, 144-155.
87. Stahl-Zeng, J., Lange, V., Ossola, R., Eckhardt, K. et al., High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites. Mol. Cell. Proteomics 2007, 6, 1809-1817.
88. Zawadzka, A. M., Schilling, B., Held, J. M., Sahu, A. K. et al., Variation and quantification among a target set of phosphopeptides in human plasma by multiple reaction monitoring and SWATH-MS2 data-independent acquisition. Electrophoresis 2014, 35, 3487-3497.
89. Guo, T., Aebersold, R., 62nd ASMS Conference on Mass Spectrometry and Allied Topics, ETH Zurich, Zurich, Switzerland 2014.
90. Collins, B. C., Gillet, L. C., Rosenberger, G., Rost, H. L. et al., Quantifying protein interaction dynamics by SWATH mass spectrometry: application to the 14-3-3 system. Nat. Methods 2013, 10, 1246-1253.
91. Lambert, J. P., Ivosev, G., Couzens, A. L., Larsen, B. et al., Mapping differential interactomes by affinity purification coupled with data-independent mass spectrometry acquisition. Nat. Methods 2013, 10, 1239-1245.
92. Goh, W. W., Wong, L., Sng, J. C., Contemporary network proteomics and its requirements. Biology 2013, 3, 22-38.
93. Christie L., Hunter, B. C., Gillet, L., Aebersold, R., ASMS 2014 Scientific Presentations, AB SCIEX, Redwood City, CA; ETH Zurich, Zurich, Switzerland 2014.
94. Picotti, P., Clement-Ziza, M., Lam, H., Campbell, D. S. et al., A complete mass-spectrometric map of the yeast proteome applied to quantitative trait analysis. Nature 2013, 494, 266-270.
95. Toprak, U. H., Gillet, L. C., Maiolica, A., Navarro, P. et al., Conserved peptide fragmentation as a benchmarking tool for mass spectrometers and a discriminating feature for targeted proteomics. Mol. Cell. Proteomics 2014.
96. Lam, H., Deutsch, E. W., Eddes, J. S., Eng, J. K. et al., Building consensus spectral libraries for peptide identification in proteomics. Nat. Methods 2008, 5, 873-875.
97. Rosenberger, G., Koh, C. C., Guo, T., Röst, H. L. et al., A repository of assays to quantify 10, 000 human proteins by SWATH-MS. Scientific Data 2014, 1, 140031.
98. Rost, H. L., Rosenberger, G., Navarro, P., Gillet, L. et al., OpenSWATH enables automated, targeted analysis of data-independent acquisition MS data. Nat. Biotechnol. 2014, 32, 219-223.
99. Bertsch, A., Gropl, C., Reinert, K., Kohlbacher, O., OpenMS and TOPP: open source software for LC-MS data analysis. Methods Mol. Biol. 2011, 696, 353-367.
100. Kunszt, P., Blum, L., Hullár, B., Schmid, E. et al., iPortal: The Swiss grid proteomics portal: Requirements and new features based on experience and usability considerations. Concurrency Computat.: Pract. Exper. 2014. DOI: 10.1002/cpe.3294.
101. Kessner, D., Chambers, M., Burke, R., Agus, D., Mallick, P., ProteoWizard: open source software for rapid proteomics tools development. Bioinformatics 2008, 24, 2534-2536.
102. Bernhardt, O. M., Selevsek, N., Gillet, L. C., Rinner, O. et al., Spectronaut: a fast and efficient algorithm for MRM-like processing of data independent acquisition (SWATH-MS) data.
103. Rosenberger, G., Ludwig, C., Rost, H. L., Aebersold, R., Malmstrom, L., aLFQ: an R-package for estimating absolute protein quantities from label-free LC-MS/MS proteomics data. Bioinformatics 2014, 30, 2511-2513.
104. Choi, M., Chang, C. Y., Clough, T., Broudy, D. et al., MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments. Bioinformatics 2014.
105. Held, J. M., Schilling, B., D'Souza, A. K., Srinivasan, T. et al., Label-free quantitation and mapping of the ErbB2 tumor receptor by multiple protease digestion with data-dependent (MS1) and data-independent (MS2) acquisitions. Int. J. Proteomics 2013, 2013, 791985.
106. Chace, D. H., Mass spectrometry in the clinical laboratory. Chem. Rev. 2001, 101, 445-477.
107. Roux, A., Lison, D., Junot, C., Heilier, J. F., Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: a review. Clin. Biochem. 2011, 44, 119-135.
108. Strathmann, F. G., Hoofnagle, A. N., Current and future applications of mass spectrometry to the clinical laboratory. Am. J. Clin. Pathol. 2011, 136, 609-616.
109. Alkhalfioui, F., Magnin, T., Wagner, R., From purified GPCRs to drug discovery: the promise of protein-based methodologies. Curr. Opin. Pharmacol. 2009, 9, 629-635.
110. Simpson, R. J., Bernhard, O. K., Greening, D. W., Moritz, R. L., Proteomics-driven cancer biomarker discovery: looking to the future. Curr. Opin. Chem. Biol. 2008, 12, 72-77.
111. Goh, W. W., Wong, L., Networks in proteomics analysis of cancer. Curr. Opin. Biotechnol. 2013, 24, 1122-1128.
112. Goh, W. W., Wong, L., Computational proteomics: designing a comprehensive analytical strategy. Drug Discov. Today 2014, 19, 266-274.